Apolipoprotein e genotype in patients with cerebrovascular diseases and its effect on the disease outcome

International Journal of Neuroscience

Volumn 119, Issue 7, 2009, Pages 919-935

  Tamam, Yusuf ^a   Tasdemir, Nebahat ^a   Toprak, Recep ^b   Tamam, Banu ^b   Iltumur, Kenan ^a  

^a DICLE UNIVERSITY   (Turkey)

^b Diyarbakir Devlet Hastanesi   (Turkey)

Author keywords

ApoE polymorphism; Cerebrovascular disease; Hemorrhagic stroke; Ischemic stroke; Outcome; Turkish population

Indexed keywords

APOLIPOPROTEIN E; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ASIAN; BLEEDING; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; STROKE; TURKEY (REPUBLIC); ALLELE; BLOOD; CASE CONTROL STUDY; CHRONIC BRAIN DISEASE; COMORBIDITY; CONVALESCENCE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HEART MUSCLE ISCHEMIA; HYPERTENSION; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEINS E; BRAIN DAMAGE, CHRONIC; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; RISK FACTORS; STROKE; TREATMENT OUTCOME; TURKEY; YOUNG ADULT;

EID: 68149092118     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450802686350     Document Type: Article

References (47)

1. Alberts, M. J., Graffagnino, C., McClenny, C., Delong, D., Strittmatter, W., Saunders, A. M., et al. (1995). ApoE genotype and survival from intracerebral hemorrhage. Lancet, 26, 575.
2. Attila, G., Acarturk, E., Eskandari, G., Akpinar, O., Tuli, A., Kanadasi, M., et al. (2001). Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey. Clinica Chimica Acta, 312, 191-196.
3. Brega, A., Scacchi, R., Cuccia, M., Kirdar, B., Peloso, G., & Corbo, R. M. (1998). Study of 15 protein polymorphisms in a sample of the Turkish population. Human Biology, 70, 715-728.
4. Catto, A. J., McCormack, L. J., Mansfield, M. W., Carter, A. M., Bamford, J. M., Robinson, P., et al. (2000). Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurologica Scandinavia, 101, 399-404.
5. Coria, F., Rubio, I., Nunez, E., Sempere, A. P., SantaEngarcia, N., Bayon, C., et al. (1995). Apolipoprotein E variants in ischemic stroke. Stroke, 26, 2375-2376.
6. Couderc, R., Mahieux, F., & Bailleul, S. (1994). Apolipoprotein E allele frequency in ischemic cerebrovascular disease and Alzheimer's disease. Stroke, 24, 1416- 1417.
7. Couderc, R., Mahieux, F., Bailleul, S., Fenelon, G., Mary, R., & Fermanian, J. (1993). Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke, 24, 661-664. (Pubitemid 23134283)
8. Di Carlo, A., Lamassa, M., Baldereschi, M., Pracucci, G., Consoli, D., Wolfe, C. D., et al. (2006). Risk factors and outcome of subtypes of ischemic stroke. Data from a multicenter multinational hospital-based registry. The European Community Stroke Project. Journal of the Neurological Sciences, 244, 143-150.
9. Dichgans, M., & Markus, H. S. (2005). Genetic association studies in stroke. Methodological issues and proposed standard criteria. Stroke, 36, 2027-2031.
10. Duzenli, S., Pirim, I., Gepdiremen, A., & Denizci, O. (2004). Apolipoprotein E polymorphism and stroke in a population from eastern Turkey. Journal of Neurogenetics, 18, 365-375.
11. Flossmann, E., & Rothwell, P. M. (2005). Family history of stroke in patients with transient ischemic attack in relation to hypertension and other intermediate phenotypes. Stroke, 36, 830-835.
12. Flossmann, E., Schulz, U. G. R., & Rothwell, P. M. (2004). Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke, 35, 212-227.
13. Frank, A., D́ýez-Tejedo, E., Bullido, M. J., Valdivieso, F., & Barreiro, P. (2002). APOE genotype in cerebrovascular disease and vascular dementia. Journal of the Neurological Sciences, 203-204, 173-176.
14. Gerdes, L. U., Klausen, I. C., Sihm, I., & Faergeman, O. (1992). Apolipoprotein E polymorphism in a Danish population compared findings in 45 other study populations around the world. Genetic Epidemiology, 9, 155-167.
15. Graffagnino, C., Gasecki, A. P., Dog, G. S., & Hachinski, V. C. (1994). The importance of family history in cerebrovascular disease. Stroke, 25, 1599-1604.
16. Hoggart, C. J., Parra, E. J., Shriver, M. D., Bonilla, C., Kittles, R. A., Clayton, D. G., et al. (2003). Control of confounding of genetic associations in stratified populations. American Journal of Human Genetics, 72, 1492-1500.
17. Kiely, D. K., Wolf, P. A., Cupples, L. A., Beiser, A. S., & Myrs, R. H. (1993). Familial aggregation of stroke: The Framingham study. Stroke, 24, 1366-1371.
18. Kim, J. S., Han, S. R., Chung, S. W., Kim, B. S., Lee, K. S., Kim, Y. I., et al. (2003). The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease. Journal of Neurological Sciences, 206, 3-5.
19. Kuusisto, J., Mykkanen, L., Kervinen, K., Kesaniemi, Y. A., & Laakso, M. (1995). Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 1280-1286.
20. Lehtinen, S., Luoma, P., Lehtimaki, T., Nayha, S., Hassi, J., & Nikkari, T. (1994). Differences in genetic variations of apolipoprotein E in Lapps and Finns. Atherosclerosis, 109, 263-268.
21. Loimaala, A., Rontu, R., Vuori, I., Mercuri, M., Lehtimaki, T., Nenonen, A., et al. (2006). Blood leukocyte count is a risk factor for intima-media thickening and subclinical carotid atherosclerosis in middle-aged men. Atherosclerosis, 188, 363-369.
22. Mahley, R. W., & Huang, Y. (1999). Apolipoprotein E: From atherosclerosis to Alzheimer's disease and beyond. Current Opinion in Lipidology, 10, 207-217.
23. Manke, C., Schuster, H, Keller, C., & Wolfram, G. (1993). The effect of the apolipoprotein E polymorphism on lipid levels in patients with familial defective apolipoprotein B-100. The Clinical Investigator, 71, 277-280.
24. McCarron, M. O., Muir, K. W., Nicoll, J. A., Stewart, J., Currie, Y., Brown, K., et al. (2000). Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Archives of Neurology, 57, 1480-1484.
25. McCarron, M. O., Muir, K. W., Weir, C. J., Dyker, A. G., Bone, I., Nicoll, J. A., et al. (1998). The apolipoprotein E epsilon4 allele and outcome in cerebrovascular disease. Stroke, 29, 1882-1887.
26. Miyata, M., & Smith, J. D. (1996). Apolipoprotein E allele-specific antioxidant activity and effects of cytotoxicity by oxidative insults and b-amyloid peptides. Nature Genetics, 14, 55-61.
27. Nakata, Y., Katsuya, T., Rakugi, H., Takami, S., Sato, N., Kamide, K., et al. (1997). Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. American Journal of Hypertension, 10, 1391-1395.
28. Nathan, B. P., Bellosta, S., Sanan, D. A., Weisgraber, K. H., Mahley, R.W., & Pitas, R. E. (1994). Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science, 264, 850-852.
29. Pedro-Botet, J., Senti, M., Nogues, X., Rubies-Prat, J., Roquer, J., D'Olhaberriague, L., et al. (1992). Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke, 23, 1556-1562.
30. Podgoreanu, M. V., & Schwinn, D. A. (2005). New paradigms in cardiovascular medicine: Emerging technologies and practices: Perioperative genomics. Journal of the American College of Cardiology, 46, 1965-1977.
31. Poirier, J. (1994). Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends in Neuroscience, 17, 525-530.
32. Rubattu, S., Gigante, B., Stanzione, R., De Paolis, P., Tarasi, D., & Volpe, M. (2004). In the search for stroke genes: A long and winding road. American Journal of Hypertension, 17, 197-202.
33. Saunders, A. M., & Roses, A. D. (1993). Apolipoprotein E allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease. Stroke, 24, 1416-1417.
34. Schulz, U. G. R., Flossmann, E., & Rothwell, P. M. (2004). Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke, 35, 819-824.
35. Sing, C. F., & Davignon, J. (1985). Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. American Journal of Human Genetics, 37, 268-285.
36. Sklavounou, E., Economou-Petersen, E., Karadima, G., Panas, M., Avramopoulos, D., Varsou, A., et al. (1997). Apolipoprotein E polymorphism in the Greek population. Clinical Genetics, 52, 216-218.
37. Sprigg, N., Gray, L. J., Bath, P. M., Lindenstrom, E., Boysen, G., De Deyn, P. P., et al. (2007). Stroke severity, early recovery and outcome are each related with clinical classification of stroke: Data from the 'Tinzaparin in Acute Ischemic Stroke Trial' (TAIST). Journal of the Neurological Sciences, 254, 54-59. (Pubitemid 46343741)
38. Stegmayr, B., Asplund, K., Kuulasmaa, K., Rajakangas, A. M., Thorvaldsen, P., & Tuomilehto, J. (1997). Stroke incidence and mortality correlated to stroke risk factors in WHO MONICA Project: An ecological study of 18 populations. Stroke, 28, 1367-1374.
39. Tan, C. E., Tai, E. S., Tan, C. S., Chia, K. S., Lee, J., Chew, S. K., et al. (2003). APOE polymorphism and lipid profile in three ethnic groups in the Singapore population. Atherosclerosis, 170, 253-260.
40. Tanaka, H., & Yokoyama, T. (1997). Cerebrovascular disease. In R. Detels and W. W. Holland (eds.), Oxford Textbook of Public Health. Oxford: Oxford University Press, 1065-1079.
41. Tang, J., Zhao, J., Zhao, Y., Wang, S., Chen, B., & Zeng, W. (2003). Apolipoprotein E epsilon 4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage. Surgical Neurology, 60, 391-396.
42. Tiret, L., de-Knijff, P., Menzel, H. J., Ehnhollm, C., Nicaud, V., & Havekes, L. M. (1994).ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS study. European atherosclerosis research study. Arteriosclerosis and Thrombosis, 14, 1617-1624.
43. Tonk, M., & Haan, J. (2007). A review of genetic causes of ischemic and hemorrhagic stroke. Journal of the Neurological Sciences, 257, 273-279.
44. Troen, A. M. (2005). The central nervous system in animal models of hyperhomocysteinemia. Progress in Neuropsychopharmacology and Biological Psychiatry, 29, 1140-1151.
45. Van Stavern, R.B. (2005). Primary intracerebral hemorrhage: Natural history, prognosis, and outcomes. Seminars in Cerebrovascular Disease and Stroke, 5, 163-167.
46. Woo, D., Sauerbeck, L. R., Kissela, B. M., Khoury, J. C., Szaflarski, J. P., Gebel, J., et al. (2002). Genetic and environmental risk factors for intracerebral hemorrhage. Preliminary results of a population-based study. Stroke, 33, 1190-1196.
47. XuGuang, G., Yang, H., & Zhiping, T. (2006). Association studies of genetic polymorphism, environmental factors and their interaction in ischemic stroke. Neuroscience Letters, 398, 172-177.